Huaxia Eye Hospital Stock Fundamentals
| 301267 Stock | 20.18 0.02 0.1% |
Huaxia Eye Hospital fundamentals help investors to digest information that contributes to Huaxia Eye's financial success or failures. It also enables traders to predict the movement of Huaxia Stock. The fundamental analysis module provides a way to measure Huaxia Eye's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Huaxia Eye stock.
Huaxia |
Huaxia Eye Hospital Company Current Valuation Analysis
Huaxia Eye's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Huaxia Eye Current Valuation | 14.22 B |
Most of Huaxia Eye's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Huaxia Eye Hospital is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Huaxia Eye Hospital has a Current Valuation of 14.22 B. This indicator is about the same for the Health Care Providers & Services average (which is currently at 14.36 B) sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is 14.49% higher than that of the company.
Huaxia Eye Hospital Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Huaxia Eye's current stock value. Our valuation model uses many indicators to compare Huaxia Eye value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Huaxia Eye competition to find correlations between indicators driving Huaxia Eye's intrinsic value. More Info.Huaxia Eye Hospital is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.59 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Huaxia Eye Hospital is roughly 1.68 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Huaxia Eye by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Huaxia Eye's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Huaxia Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Huaxia Eye's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Huaxia Eye could also be used in its relative valuation, which is a method of valuing Huaxia Eye by comparing valuation metrics of similar companies.Huaxia Eye is currently under evaluation in current valuation category among its peers.
Huaxia Fundamentals
| Return On Equity | 0.0946 | ||||
| Return On Asset | 0.0562 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 14.22 B | ||||
| Shares Outstanding | 840 M | ||||
| Shares Owned By Insiders | 84.28 % | ||||
| Shares Owned By Institutions | 5.19 % | ||||
| Price To Book | 2.93 X | ||||
| Price To Sales | 4.15 X | ||||
| Revenue | 4.09 B | ||||
| Gross Profit | 1.55 B | ||||
| EBITDA | 820.9 M | ||||
| Book Value Per Share | 6.96 X | ||||
| Earnings Per Share | 0.63 X | ||||
| Target Price | 39.75 | ||||
| Number Of Employees | 7.61 K | ||||
| Beta | 0.67 | ||||
| Market Capitalization | 19.98 B | ||||
| Annual Yield | 0 % | ||||
| Last Dividend Paid | 0.11 |
About Huaxia Eye Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Huaxia Eye Hospital's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Huaxia Eye using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Huaxia Eye Hospital based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Huaxia Eye is entity of China. It is traded as Stock on SHE exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Huaxia Stock
Huaxia Eye financial ratios help investors to determine whether Huaxia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Huaxia with respect to the benefits of owning Huaxia Eye security.